tiprankstipranks
Trending News
More News >
Sagimet Biosciences, Inc. Class A (SGMT)
:SGMT
US Market

Sagimet Biosciences, Inc. Class A (SGMT) Income Statement

Compare
1,634 Followers

Sagimet Biosciences, Inc. Class A Income Statement

Last quarter (Q3 2025), Sagimet Biosciences, Inc. Class A's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sagimet Biosciences, Inc. Class A's net income was $-12.91M. See Sagimet Biosciences, Inc. Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 2.00M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 2.00M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 54.45M$ 32.74M$ 31.05M$ 23.72M$ 11.40M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 1.00K
EBITDA
$ -45.57M$ -30.74M$ -31.05M$ -23.72M$ -11.40M
Operating Income
$ -54.45M$ -30.74M$ -31.05M$ -23.72M$ -11.40M
Other Income/Expenses
$ 8.89M$ 2.86M$ 556.00K$ -723.00K$ 30.00K
Pretax Income
$ -45.57M$ -27.88M$ -30.50M$ -24.44M$ -11.37M
Net Income
$ -45.57M$ -27.88M$ -30.50M$ -24.44M$ -11.37M
Per Share Metrics
Basic EPS
$ -1.45$ -1.53$ -1.38$ -1.10$ -0.51
Diluted EPS
$ -1.45$ -1.53$ -1.38$ -1.10$ -0.51
Weighted Average Shares Outstanding
31.35M 18.19M 22.17M 22.17M 22.17M
Weighted Average Shares Outstanding (Diluted)
31.35M 18.19M 22.17M 22.17M 22.17M
Currency in USD

Sagimet Biosciences, Inc. Class A Earnings and Revenue History